The Rowland Tostal Center in Rowland Heights, CA is a pioneering biopharmaceutical company that is revolutionizing the treatment of complex diseases. Through their innovative MINC Multi-target Immunotherapy NanoComplex Technology, they develop novel therapies that modulate multiple immune responses and signal pathways, offering high efficacy and response rates while reducing drug toxicity.
With a focus on cancer, central nervous system (CNS) disorders, and autoimmune diseases, the Rowland Tostal Center's MINC technology platform has the potential to create new biopharmaceuticals for a range of conditions, including cardiovascular diseases, infectious diseases, gene therapies, and vaccines.
Generated from the website
